Activation of myocardial angiogenesis and upregulation of fibroblast growth factor-2 in transmyocardial-revascularization-treated mice

Coron Artery Dis. 2000 Oct;11(7):537-44. doi: 10.1097/00019501-200010000-00004.

Abstract

Objective: To evaluate the growth factor responses associated with myocardial angiogenesis.

Design: Mice were treated with transmyocardial revascularization (TMR) and evaluated for angiogenic and growth factor responses.

Methods: TMR was performed via thoractomy with a 27 g needle. At 2, 5, and 7 days post-treatment, hearts were removed from the TMR treated and control groups, then assayed for angiogenesis, fibroblast growth factor (FGF)-2 expression and vascular endothelial cell growth factor (VEGF) expression.

Results: TMR caused an angiogenic reaction in the myocardial blood vessels at 7 days post-TMR treatment. Elevated FGF-2 corresponded with increased TMR related angiogenesis. VEGF levels only increased in hearts that were prewounded then TMR treated.

Conclusions: The data show that TMR stimulates myocardial angiogenesis. The angiogenic reaction is mediated by FGF-2 which increased in most experimental treatment groups. The VEGF response was more specific, requiring prewounding then TMR treatment for a VEGF increase.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Endothelial Growth Factors / physiology
  • Fibroblast Growth Factor 2 / metabolism*
  • Heart / physiology*
  • Immunohistochemistry
  • Lymphokines / physiology
  • Mice
  • Myocardial Revascularization
  • Myocardium / cytology
  • Myocardium / metabolism
  • Neovascularization, Physiologic / physiology*
  • Up-Regulation
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Wound Healing / physiology*

Substances

  • Endothelial Growth Factors
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Fibroblast Growth Factor 2